Literature DB >> 1846212

Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice.

R K Maheshwari1, V Srikantan, D Bhartiya.   

Abstract

Chloroquine (CHL) has been suggested to play an important role in the development of Burkitt's lymphoma by enhancing Epstein-Barr virus expression. Herpes zoster virus incidence is markedly increased following malaria infection in children being treated with CHL. Recently, CHL has also been shown to dramatically increase the transactivation of Tat protein purified from human immunodeficiency virus. These previous studies indirectly suggest that CHL may be involved in the enhancement of virus replication. This study demonstrates for the first time that CHL indeed enhances Semliki Forest virus and encephalomyocarditis virus replication in mice. These results raise the possible connection between the increased spread of AIDS in endemic malaria areas and the wide use of CHL in those areas for the chemotherapy of malaria.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846212      PMCID: PMC239846     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Chloroquine enhances Epstein-Barr virus expression.

Authors:  R A Karmali; D F Horrobin; J Menezes; P Patel; J Musto
Journal:  Nature       Date:  1978-10-05       Impact factor: 49.962

2.  The Epstein-Barr virus and neoplasia.

Authors:  G Klein
Journal:  N Engl J Med       Date:  1975-12-25       Impact factor: 91.245

3.  Effects of chloroquine, mefloquine and quinine on natural killer cell activity in vitro. An analysis of the inhibitory mechanism.

Authors:  B K Pedersen; I C Bygbjerg; T G Theander; B J Andersen
Journal:  Allergy       Date:  1986-09       Impact factor: 13.146

Review 4.  Interferons with special emphasis on the immune system.

Authors:  R M Friedman; S N Vogel
Journal:  Adv Immunol       Date:  1983       Impact factor: 3.543

5.  Cellular uptake of the tat protein from human immunodeficiency virus.

Authors:  A D Frankel; C O Pabo
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

6.  Effect of chloroquine and some other antimalarials on the immune mechanism in experimental animals.

Authors:  S K Bhattacharya; C R Pillai; M Mathur; P Sen
Journal:  J Pharm Pharmacol       Date:  1984-04       Impact factor: 3.765

7.  The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire.

Authors:  A E Greenberg; P Nguyen-Dinh; J M Mann; N Kabote; R L Colebunders; H Francis; T C Quinn; P Baudoux; B Lyamba; F Davachi
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272

8.  Pre-exposure rabies immunization with human diploid cell vaccine: decreased antibody responses in persons immunized in developing countries.

Authors:  K W Bernard; D B Fishbein; K D Miller; R A Parker; S Waterman; J W Sumner; F L Reid; B K Johnson; A J Rollins; C N Oster
Journal:  Am J Trop Med Hyg       Date:  1985-05       Impact factor: 2.345

9.  Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV.

Authors:  A E Greenberg; C A Schable; A J Sulzer; W E Collins
Journal:  Lancet       Date:  1986-08-02       Impact factor: 79.321

10.  Herpes zoster in children following malaria.

Authors:  I F Cook
Journal:  J Trop Med Hyg       Date:  1985-08
View more
  20 in total

1.  Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication.

Authors:  Claudia Bönsch; Christoph Kempf; Ivo Mueller; Laurens Manning; Moses Laman; Timothy M E Davis; Carlos Ros
Journal:  PLoS Negl Trop Dis       Date:  2010-04-27

2.  Chloroquine induces empty capsid formation during poliovirus eclipse.

Authors:  P Kronenberger; R Vrijsen; A Boeyé
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 3.  Antiviral perspectives for chikungunya virus.

Authors:  Deepti Parashar; Sarah Cherian
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

Review 4.  Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.

Authors:  Anwar M Hashem; Badrah S Alghamdi; Abdullah A Algaissi; Fahad S Alshehri; Abdullah Bukhari; Mohamed A Alfaleh; Ziad A Memish
Journal:  Travel Med Infect Dis       Date:  2020-05-06       Impact factor: 6.211

5.  Chikungunya disease and chloroquine treatment.

Authors:  Ilenia Delogu; Xavier de Lamballerie
Journal:  J Med Virol       Date:  2011-06       Impact factor: 2.327

Review 6.  Approaches to the treatment of disease induced by chikungunya virus.

Authors:  Jayaram Bettadapura; Lara J Herrero; Adam Taylor; Suresh Mahalingam
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

7.  In Vivo Evaluation of Withania somnifera-Based Indian Traditional Formulation ( Amukkara Choornam), Against Chikungunya Virus-Induced Morbidity and Arthralgia.

Authors:  Jaspreet Jain; Vimal Narayanan; Shivam Chaturvedi; Somnath Pai; Sujatha Sunil
Journal:  J Evid Based Integr Med       Date:  2018 Jan-Dec

8.  Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.

Authors:  Pierre Roques; Simon-Djamel Thiberville; Laurence Dupuis-Maguiraga; Fok-Moon Lum; Karine Labadie; Frédéric Martinon; Gabriel Gras; Pierre Lebon; Lisa F P Ng; Xavier de Lamballerie; Roger Le Grand
Journal:  Viruses       Date:  2018-05-17       Impact factor: 5.048

Review 9.  A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses.

Authors:  Kuan-Chieh Ching; Lisa F P Ng; Christina L L Chai
Journal:  J Antimicrob Chemother       Date:  2017-11-01       Impact factor: 5.790

Review 10.  Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy.

Authors:  Simon-Djamel Thiberville; Nanikaly Moyen; Laurence Dupuis-Maguiraga; Antoine Nougairede; Ernest A Gould; Pierre Roques; Xavier de Lamballerie
Journal:  Antiviral Res       Date:  2013-06-28       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.